Chemotherapy Market 2018-2025 | By Top Key Players: Sanofi, Novartis, Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Amgen Inc, Bayer AG, and More

Chemotherapy Market

Chemotherapy is a type of cancer treatment which consists of the use of one or more chemotherapeutic agents including anti-cancer drugs. The treatment mainly prevents the cancer cells division and growth of cancer cells by killing the dividing cells. Moreover, it is used in the treatment of different types of cancer such as lung cancer, breast cancer, leukemia, myeloma, sarcoma, lymphoma, ovarian cancer, and others.

A sample of this report is available upon request @ https://www.reportsmonitor.com/request_sample/3496

The chemotherapy drugs can be managed directly into the bloodstream or can be targeted to exact cancer sites. However, this treatment also includes several side effects such as nausea & vomiting, alopecia, hair loss, fatigue, hearing impairment, mucositis, loss of appetite, and many more.

The major key players in the Chemotherapy market are Sanofi, Novartis, Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceuticals Industries, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Chemo Espana SL, CELGENE CORPORATION, Amgen Inc, Bayer AG, Takeda Pharmaceutical Company Limited, and others.

For instance, in July 2017, TESARO, Inc. and Takeda Pharmaceutical Company Limited announced an exclusive licensing agreement for the commercialization and clinical development of novel cancer therapy ‘niraparib’, in Japan.

According to the America Cancer Society, lung cancer is estimated to be the second most common cancer in both male and female. In males, prostate cancer is more common, while in female breast cancer is more common. Additionally, about 14% of all new cancers are lung cancers. Moreover, the American Cancer Society’s evaluations for lung cancer in the United States for 2018 are:

• About 234,030 new cases of lung cancer (121,680 in men and 112,350 in women)

• About 154,050 deaths occur from lung cancer (83,550 in men and 70,500 in women)

According to the Leukemia and Lymphoma Society, around every 3 minutes, one person in the United States (US) is diagnosed with a blood cancer. Moreover, an estimated combined total of 172,910 people in the US were diagnosed with leukemia, lymphoma or myeloma in 2017.

Get Upto 50% Discount on this report @ https://www.reportsmonitor.com/check_discount/3496

Chemotherapy Market Segmentation:
By Drug:
• Alkylating Agents
o Mustard Gas Derivatives
o Ethylenimines
o Alkyl Sulfonates
o Hydrazines
o Triazines
o Others
• Antimetabolites
• Anti-Tumor Antibiotics
o Anthracyclines
o Chromomycin
• Topoisomerase Inhibitors
o Topoisomerase I Inhibitors
o Topoisomerase Ii Inhibitors
• Mitotic Inhibitors
• Others

By Indication:
• Leukemia
• Lymphoma
• Breast Cancer
• Ovarian Cancer
• Lung Cancer
• Myeloma
• Sarcoma
• Others

By Route of Drug Administration:
• Oral
• Intravenous

By End-User:
• Hospitals
• Research Institutes
• Others

Avail complete report of this research with TOC and List of Figures @ https://www.reportsmonitor.com/report/3496/Chemotherapy-Market

The market research includes information over the key industries of the Chemotherapy Market along with all the sub-segments. Additionally, the report estimates the size of the principal businesses, paired with their own share of the revenue, using astute forecasts. The research study also categorizes the market with regards to the major product types and applications.

The detailed segmentation of the Chemotherapy Market is based on the following section of this research study. The regions included in this analysis are mainly segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some of the key questions answered in this Report are:
What will be the market growth rate of Chemotherapy in the year 2018-2025?
Who are the key vendors of this market?
What are the different upcoming opportunities in the Chemotherapy market?
What are the different sales, revenue and price analysis in the market?

Available Customizations:
With the given market data, Reports Monitor offers customizations according to the company’s specific needs. The following customization options are available for the report:
The Regional and country-level analysis of the Chemotherapy Market, by end-use.
The Detailed analysis and profiles of additional market players.

About Us:
Reports Monitor is a market intelligence and consulting firm with extensive experience and knowledge of the Market Research industry.

Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics-driven intelligence. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

Contact Us:
Jay Matthews
Direct: +1 513 549-591481 (U.S.),+44 203 318 2859 (U.K.)
Email: sales@reportsmonitor.com

This release was published on openPR.